![Table 2 from Practical considerations for planning a therapeutic apheresis procedure. | Semantic Scholar Table 2 from Practical considerations for planning a therapeutic apheresis procedure. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a6775738b247cca82bceca51d7698dba9a09f217/4-Table2-1.png)
Table 2 from Practical considerations for planning a therapeutic apheresis procedure. | Semantic Scholar
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of
![Table 3 from Principles of separation: indications and therapeutic targets for plasma exchange. | Semantic Scholar Table 3 from Principles of separation: indications and therapeutic targets for plasma exchange. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bcf95f414c4871aaaee5e249d6794fa82ec3eb93/3-Table3-1.png)
Table 3 from Principles of separation: indications and therapeutic targets for plasma exchange. | Semantic Scholar
![Assessing safety and efficacy of therapeutic plasma exchange in pediatric patients: A single-center experience Chowdhry M, Mutjhukamaravel P J, Agrawal S, Gajulapali SP, Thakur UK - Asian J Transfus Sci Assessing safety and efficacy of therapeutic plasma exchange in pediatric patients: A single-center experience Chowdhry M, Mutjhukamaravel P J, Agrawal S, Gajulapali SP, Thakur UK - Asian J Transfus Sci](https://www.ajts.org/articles/2022/16/1/images/AsianJTransfusSci_2022_16_1_61_345993_t2.jpg)
Assessing safety and efficacy of therapeutic plasma exchange in pediatric patients: A single-center experience Chowdhry M, Mutjhukamaravel P J, Agrawal S, Gajulapali SP, Thakur UK - Asian J Transfus Sci
![Introduction to the Third Special Issue: Clinical Applications of Therapeutic Apheresis - McLeod - 2000 - Journal of Clinical Apheresis - Wiley Online Library Introduction to the Third Special Issue: Clinical Applications of Therapeutic Apheresis - McLeod - 2000 - Journal of Clinical Apheresis - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/9777c119-27f1-469c-93df-0253477b8db7/(sici)1098-1101(2000)15:1_2%3C1::aid-jca1%3E3.0.co;2-r.fp.png)
Introduction to the Third Special Issue: Clinical Applications of Therapeutic Apheresis - McLeod - 2000 - Journal of Clinical Apheresis - Wiley Online Library
![Pharmaceutics | Free Full-Text | Is Antimicrobial Treatment Effective During Therapeutic Plasma Exchange? Investigating the Role of Possible Interactions Pharmaceutics | Free Full-Text | Is Antimicrobial Treatment Effective During Therapeutic Plasma Exchange? Investigating the Role of Possible Interactions](https://pub.mdpi-res.com/pharmaceutics/pharmaceutics-12-00395/article_deploy/html/images/pharmaceutics-12-00395-g004.png?1588073417)
Pharmaceutics | Free Full-Text | Is Antimicrobial Treatment Effective During Therapeutic Plasma Exchange? Investigating the Role of Possible Interactions
![Therapeutic plasma exchange for children with kidney disorders: Definitions, prescription, indications, and complications Alhasan KA - Saudi J Kidney Dis Transpl Therapeutic plasma exchange for children with kidney disorders: Definitions, prescription, indications, and complications Alhasan KA - Saudi J Kidney Dis Transpl](https://www.sjkdt.org/articles/2019/30/2/images/SaudiJKidneyDisTranspl_2019_30_2_291_256835_t6.jpg)
Therapeutic plasma exchange for children with kidney disorders: Definitions, prescription, indications, and complications Alhasan KA - Saudi J Kidney Dis Transpl
![Safety and efficacy of immunoadsorption versus plasma exchange in steroid-refractory relapse of multiple sclerosis and clinically isolated syndrome: A randomised, parallel-group, controlled trial - eClinicalMedicine Safety and efficacy of immunoadsorption versus plasma exchange in steroid-refractory relapse of multiple sclerosis and clinically isolated syndrome: A randomised, parallel-group, controlled trial - eClinicalMedicine](https://www.thelancet.com/cms/attachment/6dcf8675-c0a2-4077-832f-d2a29e7c9e4c/gr1.jpg)
Safety and efficacy of immunoadsorption versus plasma exchange in steroid-refractory relapse of multiple sclerosis and clinically isolated syndrome: A randomised, parallel-group, controlled trial - eClinicalMedicine
![Daniela Hermelin, MD di Twitter: "According the newest ASFA 2019 guidelines, symptomatic #hyperviscosity in hypergammagobulinemia is a Category I indication, which means that it is a disease for which apheresis is considered Daniela Hermelin, MD di Twitter: "According the newest ASFA 2019 guidelines, symptomatic #hyperviscosity in hypergammagobulinemia is a Category I indication, which means that it is a disease for which apheresis is considered](https://pbs.twimg.com/media/D_Jp-gKWkAAOuC3.png)
Daniela Hermelin, MD di Twitter: "According the newest ASFA 2019 guidelines, symptomatic #hyperviscosity in hypergammagobulinemia is a Category I indication, which means that it is a disease for which apheresis is considered
![Introduction and overview of therapeutic apheresis - Okafor - 2010 - Journal of Clinical Apheresis - Wiley Online Library Introduction and overview of therapeutic apheresis - Okafor - 2010 - Journal of Clinical Apheresis - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a24b479f-cea5-40d8-9da2-a1bf63925334/mfig001.jpg)